HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Europe (WHO region)
Europe (WHO region): HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 53.0% in 2014. ▲ Rising
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Europe (WHO region), 2004–2014
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Europe (WHO region) is 53.0%, measured in 2014.
That represents a change of down 5.4% on the previous year and down 23.2% over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Europe (WHO region) peaked at 71.0% in 2012 and was at its lowest, 25.0%, in 2005.
The long-run direction has been consistently rising across the 11 years of available data.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2004 | 69.0% | — |
| 2005 | 25.0% | -63.8% |
| 2006 | 50.0% | +100.0% |
| 2007 | 65.0% | +30.0% |
| 2008 | 63.0% | -3.1% |
| 2009 | 54.0% | -14.3% |
| 2010 | 58.0% | +7.4% |
| 2011 | 63.0% | +8.6% |
| 2012 | 71.0% | +12.7% |
| 2013 | 56.0% | -21.1% |
| 2014 | 53.0% | -5.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 54.3% | 25.0% | 69.0% | 6 |
| 2010s | 60.2% | 53.0% | 71.0% | 5 |
More health data for Europe (WHO region)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -8.58 % change on previous year (2024)
- Number of infant deaths, annual growth rate -5.46 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Europe (WHO region)?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Europe (WHO region) was 53.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Europe (WHO region)?
- The highest recorded value was 71.0% in 2012.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Europe (WHO region)?
- The lowest recorded value was 25.0% in 2005.
- How does Europe (WHO region) rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Europe (WHO region) ranks 9th out of 11 groups with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Europe (WHO region)?
- Over the last ten years it is down 23.2%. The long-run trend across the full record is rising.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).